Association between site-of-care and the cost and modality of radiotherapy for prostate cancer: Analysis of Medicare beneficiaries from 2015 to 2017 Journal Article


Authors: Tringale, K. R.; Gennarelli, R. L.; Gillespie, E. F.; Mitchell, A. P.; Zelefsky, M. J.
Article Title: Association between site-of-care and the cost and modality of radiotherapy for prostate cancer: Analysis of Medicare beneficiaries from 2015 to 2017
Abstract: Among 84,447 radiotherapy (RT) courses for Medicare beneficiaries age ≥ 65 with prostate cancer treated with external beam RT (EBRT), brachytherapy, or both, 42,608 (51%) were delivered in hospital-affiliated and 41,695 (49%) in freestanding facilities. Freestanding centers were less likely to use EBRT + brachytherapy than EBRT (OR 0.84 [95%CI 0.84–0.84]; p <.001). Treatment was more costly in freestanding centers (mean difference $2,597 [95%CI $2,475–2,719]; p <.001). Adjusting for modality and fractionation, RT in hospital-affiliated centers was more costly (mean difference $773 [95%CI $693–853]; p <.001). Freestanding centers utilized more expensive RT delivery, but factors unrelated to RT modality or fractionation rendered RT more costly at hospital-affiliated centers. © 2021 Taylor & Francis Group, LLC.
Keywords: prostate cancer; radiation oncology; episode-based payment; site-neutrality
Journal Title: Cancer Investigation
Volume: 39
Issue: 2
ISSN: 0735-7907
Publisher: Informa Healthcare  
Date Published: 2021-01-01
Start Page: 144
End Page: 152
Language: English
DOI: 10.1080/07357907.2020.1865396
PUBMED: 33416007
PROVIDER: scopus
PMCID: PMC8285070
DOI/URL:
Notes: Article -- Export Date: 1 March 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael J Zelefsky
    754 Zelefsky
  2. Erin Faye Gillespie
    149 Gillespie
  3. Kathryn Ries Tringale
    101 Tringale